Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Zelalem Mekuria's research focuses on the epidemiology and molecular characterization of infectious diseases, particularly in Ethiopia. Recent work has investigated the co-detection of SARS-CoV-2 with influenza and human respiratory syncytial virus in Ethiopian populations, contributing to the understanding of viral respiratory illness surveillance. Mekuria has also examined the prevalence and genotypic shifts of rotavirus A among young children in Ethiopia and explored the clonal diversity and antimicrobial resistance profiles of Staphylococcus aureus in clinical settings within the country. Further research addresses broader One Health issues, including the emergence and dissemination of antimicrobial resistance at the interfaces of humans, animals, and the environment, and the use of omics technologies to tackle complex health challenges in tropical regions. Mekuria's scholarly contributions include 37 publications with an h-index of 8 and 208 total citations.
Metrics
- h-index: 8
- Publications: 37
- Citations: 208
Selected Publications
-
AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics (2025)
-
Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients (2025)
Collaboration Network
Top Collaborators
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Similar Researchers
Based on overlapping research topics